BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAPA
3026
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $29.4M | ﹤0.01% |
1,283,223
-19,947
| -2% | -$435K |
|
3027
Lands' End
LE
$390M
| $29.3M | ﹤0.01% |
1,246,236
-84,295
| -6% | -$2.9M |
|
3028
Core & Main
CNM
$8.64B
| $29.3M | ﹤0.01% |
+1,118,362
| New | +$29.8M |
|
|
SFT
3029
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $29.3M | ﹤0.01% |
422,074
-12,385
| -3% | -$992K |
|
|
SCPL
3030
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $29.2M | ﹤0.01% |
1,412,535
-934,321
| -40% | -$16.5M |
|
3031
Wheaton Precious Metals
WPM
$59.9B
| $29.2M | ﹤0.01% |
777,047
+44,457
| +6% | +$1.94M |
|
3032
Noodles & Co
NDLS
$100M
| $29.2M | ﹤0.01% |
309,302
-381
| -0.1% | -$37.3K |
|
|
ASXC
3033
DELISTED
Asensus Surgical, Inc.
ASXC
| $29.1M | ﹤0.01% |
15,720,325
+13,274
| +0.1% | +$29.8K |
|
3034
Cartesian Therapeutics
RNAC
$264M
| $29M | ﹤0.01% |
232,187
+9,154
| +4% | +$1.11M |
|
3035
GCM Grosvenor
GCMG
$2.85B
| $29M | ﹤0.01% |
2,515,279
+411,096
| +20% | +$4.46M |
|
3036
Canadian Pacific Kansas City
CP
$82.6B
| $29M | ﹤0.01% |
445,166
-10,333
| -2% | -$736K |
|
3037
Astronics
ATRO
$4.57B
| $28.8M | ﹤0.01% |
2,461,828
-66,954
| -3% | -$850K |
|
3038
UroGen Pharma
URGN
$2.34B
| $28.8M | ﹤0.01% |
1,712,223
-14,816
| -0.9% | -$235K |
|
|
PRVB
3039
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $28.7M | ﹤0.01% |
4,490,726
-56,421
| -1% | -$363K |
|
3040
Aldeyra Therapeutics
ALDX
$86.9M
| $28.7M | ﹤0.01% |
3,263,942
-11,842
| -0.4% | -$109K |
|
3041
Business First Bancshares
BFST
$1.05B
| $28.6M | ﹤0.01% |
1,222,890
-10,440
| -0.8% | -$242K |
|
3042
CALL
Twilio
TWLO
$38.3B
| $28.6M | ﹤0.01% |
89,600
+46,000
| +106% | +$16.8M |
|
3043
iShares MSCI Canada ETF
EWC
$6.55B
| $28.6M | ﹤0.01% |
786,676
+223,823
| +40% | +$8.31M |
|
3044
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $28.5M | ﹤0.01% |
949,598
+3
| +0% | +$92 |
|
3045
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $28.4M | ﹤0.01% |
881,153
-619,904
| -41% | -$20.4M |
|
3046
Digimarc Corp
DMRC
$158M
| $28.3M | ﹤0.01% |
823,145
-1,811
| -0.2% | -$53.5K |
|
3047
Traeger
COOK
$166M
| $28.3M | ﹤0.01% |
+27,070
| New | +$33.8M |
|
3048
Babcock & Wilcox
BW
$1.39B
| $28.3M | ﹤0.01% |
4,414,385
+199,625
| +5% | +$1.39M |
|
|
VLDR
3049
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $28.2M | ﹤0.01% |
4,769,333
+411,892
| +9% | +$3.1M |
|
3050
Immunovant
IMVT
$8.64B
| $28.2M | ﹤0.01% |
3,249,001
+146,214
| +5% | +$1.32M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.